Largest biotech by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Gilead Sciences leads the 24 biotech ranked by earnings, at SEK 86.5B, ahead of Amgen (SEK 78.4B) and Biogen (SEK 13.1B). Figures as of 18 Nov 2026, 15:06 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- Gilead SciencesSEK 86.5B
- Median
- -SEK 696.9M
- Combined market value
- SEK 8.63T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Gilead SciencesGILD · Health Care | SEK 86.5B | SEK 2.14T | SEK 1,725.38 | 0.28% down | 33% up | ||
| 2 | AmgenAMGN · Health Care | SEK 78.4B | SEK 2.49T | SEK 4,598.03 | 1.19% down | 34% up | ||
| 3 | BiogenBIIB · Health Care | SEK 13.1B | SEK 377B | SEK 2,550.62 | 0.08% up | 49% up | ||
| 4 | argenxARGX · Health Care | SEK 13.1B | SEK 615.4B | SEK 9,786.17 | 1.64% up | 4% up | ||
| 5 | ExelixisEXEL · Health Care | SEK 8B | SEK 171.6B | SEK 703.30 | 1.04% up | 63% up | ||
| 6 | Neurocrine BiosciencesNBIX · Health Care | SEK 4.9B | SEK 168.7B | SEK 1,666.65 | 1.15% down | 20% up | ||
| 7 | QiagenQGEN · Health Care | SEK 4.3B | SEK 104.3B | SEK 505.09 | 0.09% down | 12% up | ||
| 8 | Halozyme TherapeuticsHALO · Health Care | SEK 3.2B | SEK 112.6B | SEK 987.43 | 1.25% up | 37% up | ||
| 9 | Krystal BiotechKRYS · Health Care | SEK 2.1B | SEK 93.1B | SEK 3,140.82 | 3.53% up | 46% up | ||
| 10 | Bio-TechneTECH · Health Care | SEK 1.8B | SEK 116.1B | SEK 739.07 | 0.14% up | 26% up | ||
| 11 | RepligenRGEN · Health Care | SEK 496.9M | SEK 112.5B | SEK 1,759.52 | 6.76% up | 5% up | ||
| 12 | Adaptive BiotechnologiesADPT · Health Care | -SEK 604.6M | SEK 47.8B | SEK 295.00 | 1.90% up | 88% up | ||
| 13 | Twist BioscienceTWST · Health Care | -SEK 789.3M | SEK 82B | SEK 1,202.05 | 5.62% up | 340% up | ||
| 14 | CG OncologyCGON · Health Care | -SEK 1.6B | SEK 70.3B | SEK 786.98 | 1.89% down | 85% up | ||
| 15 | Kodiak SciencesKOD · Health Care | -SEK 2.3B | SEK 65.8B | SEK 1,006.02 | 2.27% up | 396% up | ||
| 16 | Kymera TherapeuticsKYMR · Health Care | -SEK 3.2B | SEK 107.3B | SEK 1,256.46 | 1.75% up | 87% up | ||
| 17 | ImmunityBioIBRX · Health Care | -SEK 3.6B | SEK 70.6B | SEK 66.41 | 4.39% up | 193% up | ||
| 18 | Scholar Rock HoldingSRRK · Health Care | -SEK 3.8B | SEK 59.2B | SEK 485.23 | 5.92% up | 14% up | ||
| 19 | ImmunovantIMVT · Health Care | -SEK 5.1B | SEK 71B | SEK 342.86 | 1.60% up | 43% up | ||
| 20 | CRISPR TherapeuticsCRSP · Health Care | -SEK 5.9B | SEK 41.5B | SEK 428.02 | 4.91% up | 21% down | ||
| 21 | VaxcytePCVX · Health Care | -SEK 7.8B | SEK 95.4B | SEK 602.60 | 0.17% down | 22% up | ||
| 22 | Revolution MedicinesRVMD · Health Care | -SEK 11.5B | SEK 356.2B | SEK 1,646.63 | 0.40% down | 131% up | ||
| 23 | BioNTechBNTX · Health Care | -SEK 12.8B | SEK 214.1B | SEK 863.45 | 0.13% up | 16% down | ||
| 24 | ModernaMRNA · Health Care | -SEK 28.7B | SEK 853.4B | SEK 2,109.24 | 0.37% up | 755% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1618 SEK).
Questions and answers
Which biotech rank first by earnings?
Gilead Sciences (SEK 86.5B), Amgen (SEK 78.4B) and Biogen (SEK 13.1B) are the top three of the 24 biotech ranked by earnings as of 18 Nov 2026, 15:06 UTC.
How many biotech are in this ranking?
24 are ranked by earnings.
What are these biotech worth together?
The 24 biotech ranked by earnings have a combined market value of SEK 8.63T as of 18 Nov 2026, 15:06 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest biotech by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.